drugset / Trial / NCT02609607
Treating Anorectal Dysfunction in MS
RandomizedParallel-groupTriple-blindTreatment
Summary
The investigators seek to test whether incorporating the scheduled dosing of a bisacodyl 10 mg rectal suppository every other day improves bowel-related symptoms in patients with multiple sclerosis. Patients will be randomized to receive either a placebo suppository or bisacodyl suppository dosed every other day for 4 weeks.
Timeline
- Start
- 2016-06
- Primary completion
- 2018-11
- Completion
- 2018-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Bisacodyl | Small molecule | 10 mg | Rectal |